NPIT
VIVO

National Penn Investors Trust’s Meridian Bioscience Inc VIVO Stock Holding History

National Penn Investors Trust’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-10,420
Closed -$276K – 217
2013
Q4 		$276K Sell
10,420
-110
-1% -$2.7K 0.03% 198
2013
Q3 		$249K Buy
10,530
+195
+2% +$4.55K 0.03% 194
2013
Q2 		$222K Buy
+10,335
New +$223K 0.03% 194

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

National Penn Investors Trust's VIVO Position: Q1 2014 in Review

National Penn Investors Trust sold out of Meridian Bioscience Inc (VIVO) in Q1 2014, closing a stake of 10,420 shares — an estimated $276K sold.

National Penn Investors Trust first reported a position in VIVO in Q2 2013 and held it in 3 quarters. The position peaked at $276K in Q4 2013. 166 funds tracked by Wall St. Rank hold VIVO as of Q1 2014.

  • National Penn Investors Trust reported no remaining Meridian Bioscience Inc position as of Q1 2014 after selling out during the quarter.
  • National Penn Investors Trust sold 10,420 Meridian Bioscience Inc shares in Q1 2014, an estimated $276K.
  • National Penn Investors Trust first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 3 quarters.
  • National Penn Investors Trust's Meridian Bioscience Inc position peaked at $276K in Q4 2013.
  • 166 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2014.

Based on National Penn Investors Trust's 13F filing for Q1 2014, filed 29 Apr 2014.